Carolyn Deacon’s research interests centre on the degradation and metabolism of the entero-pancreatic hormones (GLP-1, GLP-2, GIP, PYY, glucagon), the physiology and pathophysiology of the incretin hormones, and the therapeutic applications of the incretin hormones, GLP-1 analogues and DPP-4 inhibitors in the treatment of type 2 diabetes.  In particular, early studies investigating the metabolic stability of GLP-1, originating from her laboratory in the mid-1990s, have been instrumental in establishing the principle of using DPP-4 inhibition as a novel antihyperglycaemic therapy.

Academic Qualifications

• 1979: B.Sc. (Zoology); University of Sheffield, UK
• 1983: Ph.d.: University of Sheffield, UK
• 1999: D.M.Sc.; Faculty of Health Sciences, University of Copenhagen, Denmark

Appointments

• 1979-1982: Patrick and Irwin Packington Research Fellow in Zoology; University of Sheffield, UK
• 1983-1986: Post-doctoral Research Associate; Max-Planck-Gesellschaft, Göttingen, Germany
• 1987-1993: Post-doctoral Research Associate; University of Sheffield, UK
• 1993-1995: Marie Curie Fellow; University of Copenhagen, Denmark
• 1995-1998: Assistant Research Professor; University of Copenhagen, Denmark
• 1998-1999: Temporary Lecturer; University of Copenhagen, Denmark
• 2000- til nu: Associate Professor, University of Copenhagen, Denmark